comparemela.com

Latest Breaking News On - மூலக்கூறு பரிசோதனை - Page 25 : comparemela.com

Molecular Diagnostics Market Worth $ 16 58 Billion, Globally, by 2028 at 8 67 % CAGR: Verified Market Research

Molecular Diagnostics Market Worth $ 16 58 Billion, Globally, by 2028 at 8 67 % CAGR: Verified Market Research
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Molecular Diagnostics Market Worth $ 16 58 Billion, Globally, by 2028 at 8 67 % CAGR: Verified Market Research™

Molecular Diagnostics Market Worth $ 16 58 Billion, Globally, by 2028 at 8 67 % CAGR: Verified Market Research™
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

DiaSorin S p A : , in partnership with QIAGEN, launches the new LIAISON® LymeDetect® Assay based on QuantiFERON technology

Message : Required fields DIASORIN, IN PARTNERSHIP WITH QIAGEN, LAUNCHES THE NEW LIAISON® LYMEDETECT® ASSAY BASED ON QUANTIFERON TECHNOLOGY IN COUNTRIES ACCEPTING CE MARK FOR EARLY DIAGNOSIS OF LYME BORRELIOSIS THE LIAISON® LYMEDETECT® ASSAY IS A SOLUTION FOR THE EARLY DIAGNOSIS OF LYME BORRELIOSIS COMBINING DETECTION OF IGG AND IGM ANTIBODIES AND CELLULAR IMMUNITY THE TEST IS AVAILABLE IN COUNTRIES ACCEPTING THE CE MARK AND IS DESIGNED TO BE RUN ON THE LIAISON® XL AND LIAISON® XS PLATFORMS IN CLINICAL STUDIES, THE ASSAY SHOWED, WITHIN 21 DAYS FROM THE FIRST EVIDENCE OF INFECTION, A SENSITIVITY OF 74% VERSUS THAT OF EXISTING ESTABLISHED METHODS AT 49%, WHILE ALSO DEMONSTRATING A HIGH DIAGNOSTIC SPECIFICITY OF 100%

New liquid biopsy test to ID lymph node metastasis in early-stage T1 colorectal cancer

 E-Mail IMAGE: Ajay Goel, Ph.D., M.S., chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope, and his colleagues developed a novel, noninvasive liquid biopsy test for detecting. view more  Credit: City of Hope DUARTE, Calif. Scientists at City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, have developed a novel, noninvasive liquid biopsy test for detecting lymph node metastasis in individuals with high-risk T1 colorectal carcinoma. Research on the development of the blood test was reported in a new study published in Gastroenterology, a journal of the American Gastroenterological Association.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.